NCT03460626

Brief Summary

Stress affects the health and is prevalent among medicine and pharmacy students. A number of factors such as busy schedules, course load and lack of recreational time during semesters as well as exams, have been reported to be associated with stress. Study reports that the use of aroma oils especially those with relaxant properties can alleviate the level of stress. This study aims to investigate the effects of aroma oils in stress during exams in pharmacy students.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2018

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 9, 2018

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2018

Completed
Last Updated

October 5, 2021

Status Verified

September 1, 2021

Enrollment Period

2 months

First QC Date

February 19, 2018

Last Update Submit

September 27, 2021

Conditions

Keywords

stresspharmacy studentsSaudi Arabia

Outcome Measures

Primary Outcomes (5)

  • Change from baseline perceived academic stress at day 7 and at day 14

    For investigating the level of stress during examination, a subjective perceived stress scale would be given to students to report perceived academic stress. The range of this scale is from 0 to 5 where a value of 0 indicate no academic stress and value of 5 indicate severe academic stress.

    Day 1 to day 7 till day 14

  • Change in baseline mean Blood pressure at day 7 and at day 14

    For observing any change in mean blood pressure, a blood pressure monitor will be used to determine any variation in blood pressure in millimeters of mercury (mm of Hg). A total of three readings will be taken at baseline day 0, day 7 and day 14. The mean value obtained from three readings will be considered final for each time point.

    Day 1 to day 7 till day 14

  • Change in baseline heart rate at day 7 and at day 14

    For observing any change in heart rate, a blood pressure monitor will be used to determine change in heart rate in beats per minute (BPM). A total of three readings will be taken at baseline, day 7 and day 14. The mean value obtained from three readings will be considered final for each time point.

    Day 1 to day 7 till day 14

  • Change in baseline Stool consistency at day 7 and day 14

    Bristol stool chart (BST) to indicate the consistency and frequency of stools passed during this period. Bristol stool chart consists of 7 types of stools. It is a subjective assessment.

    Day 1 to day 7 till day 14

  • Change in baseline headache at day 7 and day 14

    visual analog scale (VAS) for recording the intensity of headache experienced by students during this period. Visual Analogue Scale consist of a range of 1 to 5. (1 = normal and 5 = extreme). It is a subjective self reporting instrument.

    Day 1 to day 7 till day 14

Study Arms (3)

Group-I (Control group)

PLACEBO COMPARATOR

This group will be administered a placebo that is an odorless oil without any therapeutic effect)

Other: Placebo

Group-II (Treated group)

EXPERIMENTAL

This group will be administered lavender oil.

Drug: Lavender Oil

Group-III (Untreated group)

NO INTERVENTION

No intervention will be provided in this group.

Interventions

The oil used in this study will be lavender oil with a final concentration of 3% using almond oil (90%) as diluent. The oil after dilution and final preparation will be converted to proper clean vial in a fix amount (10 ml) and given to the students.

Group-II (Treated group)
PlaceboOTHER

an odorless oil without any therapeutic effect

Also known as: An odorless oil without any therapeutic effect
Group-I (Control group)

Eligibility Criteria

Age18 Years - 24 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThis study was conducted only in the male pharmacy students.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The study includes only male student of Pharmacy college at IAU.
  • Students from 2nd to 5th year are eligible for the study.
  • All the students who are willing to participate voluntarily and are in healthy state will be included in the study.

You may not qualify if:

  • Students from other colleges as well as female students are not included in the study.
  • Any student who have no consent to participate will be excluded from this study.
  • Students with a history of stress, anxiety and depression, with any serious chronic medical conditions, any known allergy to aromatherapy or lavender oil.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Clinical Pharmacy

Dammam, Eastern Province, 31441, Saudi Arabia

Location

MeSH Terms

Interventions

lavender oil

Study Officials

  • Dr Mastour S Al Ghamdi, PhD

    Dean, College of Clinical Pharmacy

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Group-I and Group-II will be blinded to the intervention while Group-III would not be administered an intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The students will be divided into three groups randomly as Group-I (Control group: treated with a placebo that is an odorless oil without any therapeutic effect), Group-II (Treated group: administered with lavender oil) and Group-III (Untreated group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Investigator

Study Record Dates

First Submitted

February 19, 2018

First Posted

March 9, 2018

Study Start

February 2, 2018

Primary Completion

April 1, 2018

Study Completion

April 5, 2018

Last Updated

October 5, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

All data pertaining to the clinical trial will be made available after study completion.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The data will be available after March 5, 2018.

Locations